5.26
0.00
(0.00%)
May 20 - Close
NASDAQ
real-time data -
Disclaimer
Currency in USD
| Range | 5.24 - 5.31 |
| 52 week | 3.76 - 7.44 |
| Open | 5.28 |
| Vol / Avg. | 645,848.00/1.12M |
| Mkt cap | 388.85M |
| P/E | - |
| Div/yield | - |
| EPS | -0.96 |
| Shares | 73.93M |
| Beta | 1.07 |
| Inst. own | 104% |
Events
May 7, 2013
Q3 2013 Accuray Incorporated Earnings Conference Call -
May 6, 2013
Q3 2013 Accuray Incorporated Earnings Release
Mar 5, 2013
Accuray Incorporated at Cowen Health Care Conference -
|
More events from DailyFinance »
|
Key stats and ratios
| Q4 (Dec '12) | 2012 | |
| Net profit margin | -32.80% | -19.17% |
| Operating margin | -28.63% | -15.39% |
| EBITD margin | - | -7.43% |
| Return on average assets | -23.98% | -16.89% |
| Return on average equity | -60.28% | -33.87% |
| Employees | 1,100 | - |
| Carbon Disclosure Rating | - | - |
Address
1310 Chesapeake Terrace
SUNNYVALE, CA 94089
United States - Map
+1-408-7164600 (Phone)
+1-408-7164601 (Fax)
SUNNYVALE, CA 94089
United States - Map
+1-408-7164600 (Phone)
+1-408-7164601 (Fax)
Website links
External links
Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Research Reports - Reuters
Discussion Group - Google Finance
Volume delayed by 15 mins.
Advertisement
Description
Accuray, Inc. manufactures image-guided radiosurgery devices. The Company is based in the United States and its core product, the CyberKnife Stereotactic Radiosurgery System, combines image-guidance with robotics to offer unparalleled flexibility and accuracy. Accuray's focus is to revolutionize the treatment of solid cancers throughout the body by the precise delivery of high doses of radiation using the CyberKnife Stereotactic Radiosurgery System.
Officers and directors
| Louis J. Lavigne Jr. | Independent Chairperson of the Board | |
| Joshua H. Levine | President, Chief Executive Officer, Director | |
| Elizabeth H. Davila | Independent Vice Chairperson of the Board | |
| Derek A. Bertocci | Chief Financial Officer, Senior Vice President | |
| Kelly Londy | Executive Vice President, Chief Commercial Officer | |
| Robert Ragusa | Executive Vice President - Engineering and Global Operations | |
| Darren J. Milliken | Senior Vice President, General Counsel, Corporate Secretary | |
| Theresa L. Dadone | Senior Vice President - Human Resources | |
| Jack Goldstein Ph.D. | Independent Director | |
| Richard R. Pettingill | Independent Director |